Lymphoma Canada is pleased to announce the appointment of Robin Markowitz as Chief Executive Officer, effective December 4, 2013.
TORONTO, November 21, 2013 – Lymphoma Canada is pleased to announce the appointment of Robin Markowitz as Chief Executive Officer, effective December 4, 2013.
Ms. Markowitz brings 25 years of non-profit and charitable experience in senior leadership, development, marketing, and volunteer management. She is a transformational leader, most recently having worked as National Director of Development at Osteoporosis Canada. Robin also has eight years of experience working with the lymphoma community in her role as National Director of Development & Marketing at Leukemia & Lymphoma Society of Canada.
“I am honoured to lead Lymphoma Canada in their mission to support lymphoma patients and their families, fund vital research and advocate for the best treatments available. I look forward to working with the dedicated team of volunteers, donors, staff, Scientific Advisory Board and Board of Directors to further our reach within the lymphoma community.”
Ms. Markowitz replaces Sue Robson, Executive Director, who led the organization for four years before her decision to transition into a part-time position at Lymphoma Canada as Director of Advocacy & Stakeholder Relations, beginning February 1, 2014.
“Robin’s demonstrated success in fundraising and leadership will greatly increase our capacity to expand nationally and achieve our mission,” said Paul Weingarten, Chair of the Lymphoma Canada Board of Directors. “We are confident that Robin is the right leader to help take the fight against lymphoma cancer to the next level.”
Lymphoma in Canada
Lymphoma is the fifth most common cancer in Canada. As of 2013, approximately 81,000 Canadians are living with lymphoma. It affects many people, from patients, family and caregivers, to medical professionals and researchers and incidence is on the rise in young adults and children. Lymphoma is a type of blood cancer that develops when an error in the production of lymphocytes, a type of white blood cell found in the lymph nodes, results in abnormal cells that become cancerous.
About Lymphoma Canada
Lymphoma affects many people, from patients, family and caregivers, to medical professionals and researchers. Lymphoma Canada connects and empowers this community through education, support, and research. Together we are promoting early detection, finding new and better treatments, helping patients access those treatments, learning lymphoma’s many causes, and finding a cure.
For more information about this registered charity, please visit lymphoma.ca or call 1-866-659-5556.
Source: LYMPHOMA CANADA